Elena S Ratner

6PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Apr 29, 2025
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma.

Michelle Greenman, Cem Demirkiran, Stefania Bellone

|Apr 09, 2024
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Sangini S Sheth, Ji Eun Oh, Stefania Bellone

|Sep 07, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.

Levent Mutlu, Diego D Manavella, Stefania Bellone

|Aug 25, 2021
Financial toxicity in patients with gynecologic malignancies: a cross sectional study.

Burak Zeybek, Emily Webster, Natalia Pogosian

|Oct 14, 2017
Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer.

Jack M Qian, John M Stahl, Melissa R Young

Pageof 1

Frequent Collaborators

5 joint publications

Alessandro D Santin

4 joint publications

Mitchell Clark

4 joint publications

Stefania Bellone

4 joint publications

Blair McNamara